Noone, Stephanie
Flinspach, Armin N.
Fichtlscherer, Stephan
Zacharowski, Kai
Sonntagbauer, Michael
Raimann, Florian J. http://orcid.org/0000-0002-6597-9585
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 5 July 2022
Accepted: 26 October 2022
First Online: 12 December 2022
Declarations
:
: This investigation was approved by the local ethical review board (No. #20–643) of the University Frankfurt. Written consent from the patient, in accordance the guidelines of the Declaration of Helsinki, was obtained before the case report was drafted.
: Written informed consent was obtained from the patient prior to publication.
: ANF received speaker fees from P.J. Dahlhausen & Co. GmbH, Colone, Germany and received the Sedana Medical Research Grant 2020. FJR received speaker fees from Helios Germany, university hospital Würzburg and Keller Medical GmbH. FJR received financial support by HemoSonics LLC, pharma-consult Petersohn and Boehringer Ingelheim. KZ has received honoraria for participation in advisory board meetings for Haemonetics and Vifor and received speaker fees from CSL Behring and GE Healthcare. He is the Principal Investigator of the EU-Horizon 2020 project ENVISION (Intelligent plug-and-play digital tool for real-time surveillance of COVID-19 patients and smart decision-making in Intensive Care Units) and Horizon Europe 2021 project COVend (Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19). SN, SF and MS stated that they had no interests which might be perceived as posing a conflict or bias.